1 / 59

Breast Cancer

Breast Cancer. Kristi McIntyre M.D. Resident’s lecture. Breast cancer. Risk factors Hereditary breast cancer Detection Staging Surgical intervention Prognostic factors Management of early stage breast cancer. Breast cancer risk factors. Age/race

zoey
Télécharger la présentation

Breast Cancer

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Breast Cancer Kristi McIntyre M.D. Resident’s lecture

  2. Breast cancer • Risk factors • Hereditary breast cancer • Detection • Staging • Surgical intervention • Prognostic factors • Management of early stage breast cancer

  3. Breast cancer risk factors • Age/race • Reproductive issues/Estrogen-related factors • Breast histology • Life style factors • Family history/Genetic factors

  4. Breast Cancer Risk Factors

  5. Breast Cancer Incidence

  6. Race/Ethnicity and Breast Cancer Risk Annual incidence Caucasian 137 African Americans 120 Hispanic 82 Asian 93 American Indian59 SEER results: age adjusted only Jemal CA:Cancer J.Clin ;2003,53:5

  7. Race/Ethnicity and Breast Cancer Risk “Adjusted Hazard Ratios” 0.4 0.6 0.8 1.0 1.2 .72 African American Hispanics American Indian Asian Only African Americans had lower breast cancer risk (p=o.oo6) than Caucasians Cheblowski JNCI ;March 2005

  8. Race/Ethnicity and Breast Cancer Risk Combined Grade III and ER negative by race Cheblowski JNCI ;March 2005

  9. Race/Ethnicity and Breast Cancer Risk • Differences in breast cancer incidence rates between most ethnic groups can largely be explained by control of risk factors • African American women are at significantly reduced risk • African American women have a higher proportion of unfavorable features suggesting cause for higher mortality rates Cheblowski JNCI ;March 2005

  10. Reproductive Factors and Breast Cancer Menarche < 16 Menopause >50 Menarche <16 OR 1.2 Menopause >50 OR 1.5 Null parity OR 2.0 Breastfeeding 4.3% decrease risk/yr First live birth<20 OR 0.5 First live birth >35 OR 1.5

  11. WHI Trial of Estrogen plus Progestin E+P placebo p-value Invasive Breast cancers 199 150 0.003 SEER high stage 25% 16% 0.041 Abnormal Mammograms 716 395 0.0001 More breast cancers diagnosed at more advanced stage and increased abnormal mammograms More breast cancers diagnosed at more advanced stage and increased abnormal mammograms Chlebowski JAMA 2003;289. 3243

  12. Breast histology and breast cancer risk Benign breast disease RR Fibrocystic disease 0 Atypical ductal hyperplasia 4.3 Atypical ductal hyperplasia and 11.0 family history

  13. Risk Factors for Breast Cancer Family History Risk • First Degree relative • Premenopausal diagnosis 3.0 • Bilateral disease 5.0 • Premenopausal diagnosis and bilateral disease 9.0 • Postmenopausal diagnosis 1.5 • Second Degree relative • Premenopausal diagnosis 1.2 • Postmenopausal diagnosis 0

  14. Hereditary

  15. Family history and breast cancer risk Most hereditary breast cancers arise from mutations in BRCA1 and BRCA2 Autosomal dominant , tumor suppressor gene

  16. BRCA mutations and lifetime cancer risk 50-85% breast cancer 50% Second breast cancers 15-45% ovarian cancer risk Other malignancies: prostrate pancreatic male breast cancer

  17. Founder mutations and Breast cancer • Ethnic background should be considered in risk assessment for breast cancer • “ Founder” gene mutations discovered in individuals of Ashkenazi Jewish descent • 50-90 % have gene susceptibility with positive family history • Founder mutations have been found in populations of Iceland,Finland, France, Holland , Russia,and Sweden

  18. Models for risk assessment Claus model Gail model http://bcra.nci.nih.gov/brc Age Age first live birth Age first menses FH-maternal only; no age # prior breast biopsies/ADH race Family history Age at diagnosis Both models inadequate : not useful for mutation carriers or individual risk www3.utsouthwestern.edu/cancergene/

  19. Lifestyle factors and breast cancer risk • Body mass index: postmenopausal women >30% excess BMI increased risk • Dietary fat intake: increased risk • NSAID use: decreases risk • Physical activity: 1.25 to 2.5/hrs week brisk walking had 18 % decrease risk • Smoking : increased risk • Alcohol use: increased (dose dependent)

  20. Risk Reduction Strategies Average Risk • Early childbirth • Exercise • Maintain normal weight • Avoid smoking/alcohol • Avoid prolonged HRT Moderate Risk • Chemoprevention

  21. Most breast cancers are non palpable masses discovered only on screening mammograms Malignant breast densities have irregular borders, are stellate and distort surrounding architecture

  22. Breast Cancer Detection • United States Preventive Services Task Force • Mammogram every 1-2 years for female age 40-49(average risk) • Age > 50 annual mammography and clinical exam • Age > 70 debatable Mammography detects only 85% of biopsy proven breast cancer hence not a substitute for tissue sampling of palpable mass

  23. Breast Cancer Screening There is almost universal agreement that randomized controlled trials of screening have demonstrated death rate from breast cancer can be reduced by periodic screening with mammography

  24. MRI Breast • Implant evaluation • Axillary adenopathy ?occult primary • Breast cancer patients (extent of disease, response to neoadjuvant therapy) • Screening evaluation for high risk patient • Further evaluation of mammographic abnormality

  25. Staging of breast cancer Estimate extent of disease Determine prognosis Guide therapy

  26. Staging of breast cancer • Stage 0 (DCIS) • Stage I node negative • Stage II node positive • Stage III advanced node • Stage IV distant metastasis 2003 AJCC staging change • Distinction between micrometastasis and isolated tumor cells • Identifiers for sentinel nodes • #number of positive LN

  27. Management of Early stage breast cancer 1950 Halsted “radical mastectomy” “breast cancer spreads in an orderly fashion” 12% 10 year survival 20-30% node negative breast cancer patients will develop metastatic disease Micrometastatic disease paradigm

  28. Management of Early stage breast cancer MORE LESS Radical Mastectomy Whole breast radiation Axillary dissection Lumpectomy Partial breast radiation Sentinel node biopsy

  29. Surgical intervention for Breast Cancer NSABP B-04 Total Mastectomy + Axillary dissection Lumpectomy + Breast radiation Lumpectomy alone No difference in Overall Survival or Disease Free Survival (20 year follow-up) Fisher et al.NEJM2002;347:1456-61

  30. Surgical Intervention of Breast Cancer • NSABP B-04 • Cumulative incidence of ipsilateral breast cancer • Standard of care: lumpectomy+ Xrt 39% 14%

  31. Surgical intervention for Breast Cancer NSABP B-04 Fisher,et al.NEJM(2002):347;1454-61

  32. Surgical Staging of Axilla Axillary dissection= removal of level I and Level II lymph nodes Morbidity : wound infection motion restriction arm stiffness pain lymphedema

  33. Sentinel node mapping

  34. Chemotherapy for early stage breast cancer

  35. Prognostic factors in Breast cancer Recognized Factors Potential factors Proliferative index Tumor grade Vascular invasion Her- 2 Gene microarray Nodal status Tumor size Histologic type ER/PR

  36. Prognostic factors in Breast cancer The most significant prognostic indicator for patients with early stage breast cancer is the presence or absence of axillary lymph node involvement.

More Related